Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Medimarker's Laboratories

Pharmaceutical manufacturer · Pakistan

Pakistan pharmaceutical manufacturer represented in the DRAP PharmaPrice source with DML-linked registered products.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence1 sourceCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Corporate source details checked
16 Aug 2026
Corporate profile completeness
38%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000615 Medimarker's Pharmaceuticals (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000615 74 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Exact site not yet sourced

No exact premises location is published without a defensible source.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx77public portfolio records represented
REG73unique registrations represented
IDX75indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+2registry-only registrations
VER0registry-verified exact registrations
PKR71current validated price records
G36generic molecules in indexed catalogue
DF10dosage-form groups
TA9therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage92%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage97%
priced packs safely normalized per unit
Comparable-market coverage92%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixMedimarker's LaboratoriesShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medimarkers-laboratoriesGenerated 23 Sep 2026Anti-infectives48 · 64%Pain & musculoskeletal6 · 8%Vitamins, minerals & nutrition5 · 7%Respiratory & allergy5 · 7%Fluids & supportive care5 · 7%Cardiovascular2 · 3%CNS & mental health2 · 3%Other therapeutic areas2 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioMedimarker's LaboratoriesDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medimarkers-laboratoriesGenerated 23 Sep 202675presentationsTablet23 · 31%Injection19 · 25%Suspension8 · 11%Capsule6 · 8%Infusion6 · 8%Syrup5 · 7%Other forms8 · 11%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionMedimarker's LaboratoriesCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medimarkers-laboratoriesGenerated 23 Sep 202669comparable productsBelow peer median25 · 36%Near peer median25 · 36%Above peer median19 · 28%Company median price position-0.5%Lowest-price equivalents9Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsMedimarker's LaboratoriesCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medimarkers-laboratoriesGenerated 23 Sep 2026Mediate Pharmaceutical Pvt Ltd29 shared81% overlapS.J & G. Fazul Ellahie (pvt) limite…25 shared69% overlapPulse Pharmaceuticals (Pvt.) Ltd.25 shared69% overlapPharmasol (Pvt) Ltd.24 shared67% overlapZafa Pharmaceutical Laboratories (P…24 shared67% overlapBarrett Hodgson Pakistan (Pvt.) Ltd24 shared67% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives48 products · 64%
Pain & musculoskeletal6 products · 8%
Vitamins, minerals & nutrition5 products · 7%
Respiratory & allergy5 products · 7%
Fluids & supportive care5 products · 7%
Cardiovascular2 products · 3%
CNS & mental health2 products · 3%
Hematology & thrombosis1 products · 1%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Third-generation cephalosporins12 products · 16%
Fluoroquinolone antibacterials12 products · 16%
Analgesics / NSAIDs6 products · 8%
Macrolide antibacterials5 products · 7%
Vitamins / minerals / hematinics5 products · 7%
Fluids, electrolytes & diluents5 products · 7%
Second-generation cephalosporins5 products · 7%
Penicillin antibacterials4 products · 5%
Formulation footprint

Dosage forms

Tablet23 products
Injection19 products
Suspension8 products
Capsule6 products
Infusion6 products
Syrup5 products
Cream3 products
Drops3 products
Sachet1 products
Solution1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 CefmarkCeftriaxone 5presentations 1 g, 250 mg, 500 mg · Injection #2 RoxlitCefuroxime 5presentations 1.5 g, 250 mg, 250 mg/5 mL, 750 mg · Infusion, Injection, Suspension #3 MoxilabMoxifloxacin 4presentations 0.5%, 400 mg · Drops, Infusion, Tablet #4 PotradolParacetamol 4presentations 1000 mg/100 mL, 120 mg/5 mL, 250 mg/5 mL, 500 mg · Infusion, Syrup, Tablet #5 AmoxicillinAmoxicillin 3presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL · Suspension, Capsule #6 C-MarkerClarithromycin 3presentations 125 mg/5 mL, 250 mg, 500 mg · Syrup, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2536% of comparable products
Near market median25within ±5% of median
Above market median1928% of comparable products
Lowest-price equivalents9ties included
Company median price position -0.5% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Roxlit 1.5 gCefuroxime · Dry powder for injection · 1's PKR 192.12/vial/unit-42.6% vs market median Roxlit 750 mgCefuroxime · Dry powder for injection · 1's PKR 115.84/vial/unit-40.3% vs market median Med-Lecal 5ml 5 mgCholecalciferol · Injection · 1mlx5's(Ampoule) PKR 112.36/mL-39.9% vs market median Markonza 2 %Miconazole · Cream · 20gm PKR 4.80/g-37.4% vs market median Liv-Mark 500 mg/100 mLLevofloxacin · IV infusion · 100ml vial PKR 4.62/mL-31.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 29shared generics S.J & G. Fazul Ellahie (pvt) limited.193 products · 68 generics 25shared generics Pulse Pharmaceuticals (Pvt.) Ltd.116 products · 48 generics 25shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 24shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 24shared generics Barrett Hodgson Pakistan (Pvt.) Ltd187 products · 63 generics 24shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers71Distinct registrations among indexed, published, presentation-validated products only
Verified price observations75
Products with a verified price75
Products with multiple price observations0
Source records with multiple versions73
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

73 unique registration(s) · 75 indexed presentation(s) · 2 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Mednophen Phenobarbital 30 mg Tablet 100's 061004 PKR 75.72 PKR 0.76/tablet 15% below median
Moxilab Moxifloxacin 400 mg IV infusion 250ml vial 100412 PKR 1,846.59 PKR 7.39/mL Near median
Moxilab Moxifloxacin 0.5% Ophthalmic drops 5ml 101028 PKR 507.81 PKR 101.56/mL Near median
Moxilab Moxifloxacin 0.5% Ophthalmic drops 3ml 101028 PKR 304.69 PKR 101.56/mL Near median
Moxilab Moxifloxacin 400 mg Tablet 5's 118010 PKR 981.04 PKR 196.21/tablet 6% above median
MP-Lyte Sodium chloride + Dextrose + Potassium chloride + Sodium citrate NaCl 1.75g + KCl 0.75g + Na citrate 1.45g + Dextrose 10g/500 mL Solution 500ml 048619 PKR 73.86 PKR 0.15/mL 5% below median
MP-Lyte O.R.S. (WHO Formulation) Sodium chloride + Potassium chloride + Trisodium citrate dihydrate + Glucose anhydrous 1.3 g + 0.75 g + 1.45 g + 6.75 g Sachet 20's 047298 PKR 521.15 PKR 26.06/sachet 22% above median
Omemark Omeprazole 20 mg Capsule 14's 047297 PKR 265.91 PKR 18.99/capsule Near median
Pflomark Ofloxacin 200 mg Tablet 10's 047086 PKR 212.36 PKR 21.24/tablet 7% below median
Potradol Paracetamol 250 mg/5 mL Syrup 60ml 047070 PKR 97.63 PKR 1.63/mL No comparator
Potradol Paracetamol 120 mg/5 mL Syrup 60ml 047075 PKR 67.86 PKR 1.13/mL 8% above median
Potradol Paracetamol 500 mg Tablet 20x10's 048684 PKR 515.01 PKR 2.58/tablet 29% below median
Potradol Paracetamol 1000 mg/100 mL IV infusion 100ml vial 100413 PKR 147.73 PKR 1.48/mL No comparator
Rifodime Ceftazidime 250 mg Injection 1's 100391 PKR 159.64 PKR 159.64/vial/unit Near median
Rifodime Ceftazidime 1 g Injection 1's 100392 PKR 456.12 PKR 456.12/vial/unit Near median
Roxlit Cefuroxime 250 mg/5 mL Dry suspension 50ml 100400 PKR 553.98 PKR 11.08/mL 21% above median
Roxlit Cefuroxime 1.5 g Powder for solution for injection/infusion 1's 117909 PKR 192.12 PKR 192.12/vial/unit No comparator
Roxlit Cefuroxime 1.5 g Dry powder for injection 1's 117909 PKR 192.12 PKR 192.12/vial/unit 43% below median
Roxlit Cefuroxime 750 mg Dry powder for injection 1's 117910 PKR 115.84 PKR 115.84/vial/unit 40% below median
Roxlit Cefuroxime 250 mg Dry powder for injection 1's 117911 PKR 57.83 PKR 57.83/vial/unit 6% above median
Signovit Cyanocobalamin 1000 mcg/mL Injection 1ml x 25's ampoules 100407 PKR 106.18 — No comparator
Water for Injection Water for Injection 10 mL Injection 10ml 100406 PKR 22.16 PKR 2.22/mL 9% above median
Water for Injection Water for Injection 5 mL Injection 5mlx100's 117906 PKR 1,211.25 PKR 2.42/mL 22% above median
Water for Injection Water for Injection 5 mL Injection 5mlx1's 117906 PKR 13.17 PKR 2.63/mL 32% above median
Welltika Montelukast 5 mg Tablet 14's 047090 PKR 517.04 PKR 36.93/tablet 11% above median
Welltika Montelukast 10 mg Tablet 14's 047091 PKR 572.44 PKR 40.89/tablet Near median
Welltika Montelukast 4 mg Tablet 14's 048683 PKR 349.00 PKR 24.93/tablet Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Medimarker's Laboratories — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/medimarkers-laboratories/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.